Shares of Core Laboratories (NYSE: CLB) had declined 13.3% over the past week as of 3:15 p.m. EDT on Thursday. On Monday, an analyst from Citi downgraded shares of Core Labs from neutral to sell. The analyst also set their price target at $36 per share, still about 15% below the most recent price.
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting